Confederation of Indian Industry (CII) has submitted several key recommendations to the Department of Pharmaceuticals (DoP) with regards to the infrastructure support required to boost manufacturing in the medical technology sector in line with the government’s “Make in India” mission.
Regarding implementation of the Preferential Market Access (PMA) Policy in medical equipment and device, the industry members recommended promoting the components and ancillary industry without which “Making in India” is not possible in this technology-driven sector, said CII.
It suggested that attracting big global medical technology companies to India will help create a base which will then build up the components ecosystem.
To begin with, only MSME / SME industry components can be given preference in the PMA policy, it said.
CII also suggested subsidised land prices for setting up medical devices industry in medical technology hubs.
The process of setting up manufacturing facilities needs to be streamlined by designating medical technology hubs all over the country with the right infrastructure in place to support complex medical technology manufacturing, it said.